Feed aggregator

Birth Control Market Evolves as OTC Opill Hits US Stores

Biospace news - Fri, 10/04/2024 - 02:00
Birth Control Market Evolves as OTC Opill Hits US Stores 4/10/2024

Can $12 Billion Jumpstart Women’s Health?

Biospace news - Fri, 10/04/2024 - 02:00
Can $12 Billion Jumpstart Women’s Health? 4/10/2024

Alphabet Soup: AACR and ACC Dominate Headlines This Week

Biospace news - Fri, 10/04/2024 - 02:00
Alphabet Soup: AACR and ACC Dominate Headlines This Week 4/10/2024

YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial

Biospace news - Fri, 10/04/2024 - 02:00
YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial 4/10/2024

AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit

Biospace news - Fri, 10/04/2024 - 02:00
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit 4/10/2024

7 Billion-Dollar Oncology M&As from Q1

Biospace news - Fri, 10/04/2024 - 02:00
7 Billion-Dollar Oncology M&As from Q1 4/10/2024

The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.

Biospace news - Fri, 10/04/2024 - 02:00
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That. 4/10/2024

Poor Customer Data Management Costs Pharma Companies Money: Report

Biospace news - Fri, 10/04/2024 - 02:00
Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024

AACR 2024: What Cancer Researchers Are Talking About

Biospace news - Fri, 10/04/2024 - 02:00
AACR 2024: What Cancer Researchers Are Talking About 4/10/2024

Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs

Biospace news - Thu, 09/05/2024 - 02:00
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024

Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024

Biospace news - Thu, 09/05/2024 - 02:00
Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024 5/9/2024

Women's Health: Where Politics and Science Meet

Biospace news - Thu, 09/05/2024 - 02:00
Women's Health: Where Politics and Science Meet 5/9/2024

Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies

Biospace news - Thu, 09/05/2024 - 02:00
Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies 5/9/2024

Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds

Biospace news - Thu, 09/05/2024 - 02:00
Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds 5/9/2024

Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases

Biospace news - Thu, 09/05/2024 - 02:00
Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases 5/9/2024

Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop

Biospace news - Thu, 09/05/2024 - 02:00
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop 5/9/2024

DEIB Evolves As Criticism, Changing Attitudes Continue

Biospace news - Thu, 09/05/2024 - 02:00
DEIB Evolves As Criticism, Changing Attitudes Continue 5/9/2024

Dry Promotions: Dealing With a Double-Edged Sword

Biospace news - Thu, 09/05/2024 - 02:00
Dry Promotions: Dealing With a Double-Edged Sword 5/9/2024

Top 5 Companies Hiring in the Boston Area

Biospace news - Thu, 09/05/2024 - 02:00
Top 5 Companies Hiring in the Boston Area 5/9/2024

Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data

Biospace news - Wed, 09/04/2024 - 02:00
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data 4/9/2024